ctrl K

AI Score

Unlock

MiNK Therapeutics Inc. (INKT)

AI Score

Unlock

8.50

-0.45 (-5.03%)

At close: Mar 03, 2025, 3:58 PM

8.79

3.44%

After-hours: Mar 03, 2025, 03:58 PM EST

MiNK Therapeutics Income Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Revenue	n/a	2.7B	n/a	n/a	689.63K
Cost of Revenue	204.62K	30.95B	28.36B	55.06K	n/a
Gross Profit	-204.62K	-28.24B	-28.36B	-55.06K	689.63K
Operating Income	-22.92M	-30.95M	-28.36M	-14.64M	-22.28M
Interest Income	463.26K	253.32K	2.43K	2.44K	1.56K
Pretax Income	-22.46M	-27.99M	-30.21M	-16.24M	-23.8M
Net Income	-22.46M	-24.78M	-23.11M	-15.68M	-25.91M
Selling & General & Admin	7.43M	7.83M	4.64M	1.29M	3.83M
Research & Development	15.49M	23.12M	13.97M	9.51M	19.65M
Other Expenses	n/a	2.7M	-9.53M	-3M	551.24K
Operating Expenses	22.92M	30.95M	18.61M	10.8M	23.48M
Interest Expense	n/a	253.32K	2.43M	2.44M	1.56M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	22.92M	30.95M	18.61M	10.8M	23.48M
Income Tax	n/a	-3.21M	-7.1M	-560.38K	2.11M
Shares Outstanding (Basic)	34.36M	33.67M	33.48M	33.09M	33.09M
Shares Outstanding (Diluted)	34.36M	33.67M	33.48M	33.09M	33.09M
EPS (Basic)	-0.65	-0.74	-0.69	-0.47	-0.78
EPS (Diluted)	-0.65	-0.74	-0.69	-0.47	-0.78
EBITDA	-22.25M	-30.83M	-27.7M	-13.74M	-22.2M
Depreciation & Amortization	204.62K	121.75K	77.96K	55.06K	36.82K